ChemoCommunity

Characterizing chemoresponse communities at transcriptional and post-transcriptional levels.

Compound Details

The detailed records of NSC 266046 were elucidated in the following 4 sections: 1) Basis: basic information about NSC 266046; 2) Community: the network communities that were significantly associated with the response to NSC 266046; 3) Molecule: the relationships between components within communities and NSC 266046; 4) MDR: the compounds that were significantly associated with the NSC 266046.

NSC Compound Enrichment Correlation
NSC 696660 (6R,6S)-2,4-Diamino-6-(3,4-dimethoxybenzyl)-5,6,7,8-tetrahydroquinazoline 0.0145418727063286 0.21049123
NSC 744622 4,8,13,17,21-Pentamethyl-docosa-4,8,12,16,20-pentaenoic acid[1-(3,3-difluoro-4-hydroxy-5-hydroxymethyl-tetrahydro-furan-2-yl)-2-oxo-1,2-dihydro-pyrimidin-4-yl]-amide 0.0145418727063286 0.06727482
NSC 752385 Null 0.0145418727063286 0.32177755
NSC 668258 Null 0.0149636429145595 0.47931718
NSC 679092 Null 0.0149636429145595 -0.3916948
NSC 716535 Null 0.0149636429145595 0.41884128
NSC 249956 CHAPLIATRIN 0.0149636429145596 0.48741028
NSC 112758 Rubomycin 0.0186186224062458 0.3749622
NSC 112846 N-[p-[[(2,4-Diamino-6-quinazolinyl)methyl]amino]benzoyl]-L-aspartic acid 0.0186186224062458 0.34395367
NSC 16258 Null 0.0186186224062458 0.47722584
Total:138  Current:66    [First] [Prev] [Next] [Last]